CSIMarket



Beam Therapeutics Inc   (BEAM)
Other Ticker:  
 
 

BEAM's Revenue Growth by Quarter and Year

Beam Therapeutics Inc 's Revenue results by quarter and year




BEAM Revenue (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 51.07 0.01 0.09
III Quarter September - 0.76 0.01 1,334.40
II Quarter June - 0.01 0.01 598.70
I Quarter March 8.43 0.01 0.01 637.60
FY   8.43 51.85 0.04 2,570.79



BEAM Revenue first quarter 2022 Y/Y Growth Comment
Beam Therapeutics Inc achieved in the first quarter 2022, above Company average Revenue surge of 84220% year on year, to $ 8.43 millions.

Looking into first quarter 2022 results within Biotechnology & Pharmaceuticals industry 22 other companies have achieved higher Revenue growth. While Beam Therapeutics Inc ' s Revenue doubling of 84220% ranks overall at the positon no. 302 in the first quarter 2022.




BEAM Revenue ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - 510600 % -88.89 % -99.98 %
III Quarter September - 7500 % -100 % 88.18 %
II Quarter June - 0 % -100 % -4.59 %
I Quarter March 84220 % 0 % -100 % 7.07 %
FY   - 129525 % -100 % 2.43 %

Financial Statements
Beam Therapeutics Inc 's first quarter 2022 Revenue $ 8.43 millions BEAM's Income Statement
Beam Therapeutics Inc 's first quarter 2021 Revenue $ 0.01 millions Quarterly BEAM's Income Statement
New: More BEAM's historic Revenue Growth >>


BEAM Revenue (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - 6619.74 % 0 % -99.99 %
III Quarter September - 7500 % 0 % 122.88 %
II Quarter June - 0 % 0 % -6.1 %
I Quarter March -83.49 % 0 % -88.89 % 10.37 %
FY (Year on Year)   - 129525 % -100 % 2.43 %




Revenue first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #23
Healthcare Sector #88
Overall #302

Revenue Y/Y Growth Statistics
High Average Low
6538.16 % 336.55 % -99.99 %
(Dec 31 2021)   (Sep 30 2020)
Revenue first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #23
Healthcare Sector #88
Overall #302
Revenue Y/Y Growth Statistics
High Average Low
6538.16 % 336.55 % -99.99 %
(Dec 31 2021)   (Sep 30 2020)

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Beam Therapeutics Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
12616.67 % 599.74 % -83.49 %
(Sep 30 2021)   (Mar 31 2022)


BEAM's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2022 Beam Therapeutics Inc realized fall in Revenue from the previous quarter by -83.49% to $ 8.43 millions, from $ 51.07 millions declared a quarter before.

Within Biotechnology & Pharmaceuticals industry 97 other companies have achieved higher Revenue quarter on quarter growth. While Beam Therapeutics Inc 's Revenue growth quarter on quarter, overall rank is 3018.


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #98
Healthcare Sector #507
Overall #3018
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #98
Healthcare Sector #507
Overall #3018
Revenue Q/Q Growth Statistics
High Average Low
12616.67 % 599.74 % -83.49 %
(Sep 30 2021)   (Mar 31 2022)


BEAM's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2022 Beam Therapeutics Inc reported fall in Revenue from the forth quarter by -83.49% to $ 8.43 millions, from $ 51.07 millions declared a quarter before.

Within Biotechnology & Pharmaceuticals industry 97 other companies have achieved higher Revenue quarter on quarter growth. While Beam Therapeutics Inc 's Revenue growth quarter on quarter, overall rank is 3018.


Beam Therapeutics Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative Revenue 12 Months Ending $ 60.27 $ 51.84 $ 0.78 $ 0.02 $ 0.02
Y / Y Revenue Growth (TTM) 251025 % 215916.67 % 640.5 % -100 % -100 %
Year on Year Revenue Growth Overall Ranking # 2 # 2 # 35 # 3695 # 3660
Seqeuential Revenue Change (TTM) 16.25 % 6538.16 % 3154.17 % 0 % 0 %
Seq. Revenue Growth (TTM) Overall Ranking # 302 # 4 # 3 # 3193 # 2367




Cumulative Revenue growth Comment
With 251025% annual Revenue growth, Beam Therapeutics Inc would report a record annual Revenue surge if the fiscal year would end on Mar 31 2022.

Beam Therapeutics Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. 2.

Revenue TTM Q/Q Growth Statistics
High Average Low
6538.16 %
336.55 %
-99.99 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 23
Healthcare Sector # 1
Overall # 2

Revenue TTM Y/Y Growth Statistics
High Average Low
251025 %
16674.64 %
-100 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 23
Sector # 88
S&P 500 # 302
Cumulative Revenue growth Comment
With 251025% annual Revenue growth, Beam Therapeutics Inc would report a record annual Revenue surge if the fiscal year would end on Mar 31 2022.

Beam Therapeutics Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. 2.

Revenue TTM Q/Q Growth Statistics
High Average Low
6538.16 %
336.55 %
-99.99 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 23
Healthcare Sector # 1
Overall # 2

Revenue TTM Y/Y Growth Statistics
High Average Low
251025 %
16674.64 %
-100 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 23
Sector # 88
S&P 500 # 302




Other Revenue Growth
Biotechnology & Pharmaceuticals Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
BEAM's Revenue Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for BEAM's Competitors
Revenue Growth for Beam Therapeutics Inc 's Suppliers
Revenue Growth for BEAM's Customers

You may also want to know
BEAM's Annual Growth Rates BEAM's Profitability Ratios BEAM's Asset Turnover Ratio BEAM's Dividend Growth
BEAM's Roe BEAM's Valuation Ratios BEAM's Financial Strength Ratios BEAM's Dividend Payout Ratio
BEAM's Roa BEAM's Inventory Turnover Ratio BEAM's Growth Rates BEAM's Dividend Comparisons



Companies with similar Revenue surge for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2022
Dyadic International Inc140,703.22%$ 140,703.222 millions
Beam Therapeutics Inc 140,433.33%$ 140,433.333 millions
Skinovation Pharmaceutical Incorporated88,465.15%$ 88,465.154 millions
Vir Biotechnology Inc 62,271.41%$ 62,271.407 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

AYTU's Profile

Stock Price

AYTU's Financials

Business Description

Fundamentals

Charts & Quotes

AYTU's News

Suppliers

AYTU's Competitors

Customers & Markets

Economic Indicators

AYTU's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071